申请人:Akatsuka Hidenori
公开号:US20100240644A1
公开(公告)日:2010-09-23
The present invention provides a morpholine derivative of the formula [I];
wherein R
1
is a substituted alkyl group, an optionally substituted aryl group, an optionally substituted heterocyclo group, a cycloalkyl group or an alkyl group; R
2
is a substituted alkyl group, an optionally substituted aryl group, an optionally substituted heterocyclo group, an optionally substituted alkylcarbonyl group, an optionally substituted arylcarbonyl group, an optionally substituted heterocyclo-substituted carbonyl group or a cycloalkylcarbonyl group; T is a methylene group or a carbonyl group; R
3
, R
4
, R
5
and R
6
are the same or different and a hydrogen atom, an optionally substituted carbamoyl group or an optionally substituted alkyl group;
or pharmaceutically acceptable salts thereof.
These compounds are useful as a renin inhibitor.
本发明提供了公式[I]的吗啡啶衍生物;其中R1是取代的烷基,可选取代的芳基,可选取代的杂环基,环烷基或烷基;R2是取代的烷基,可选取代的芳基,可选取代的杂环基,可选取代的烷基羰基,可选取代的芳基羰基,可选取代的杂环取代羰基或环烷基羰基;T是亚甲基或羰基;R3,R4,R5和R6相同或不同,是氢原子,可选取代的氨基甲酰基或可选取代的烷基;或其药学上可接受的盐。这些化合物可用作肾素抑制剂。